ArticleTranslational oncology2024

New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.

Tobias Kiesslich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.